Download PDFPDF

1201 SGN-BB228 is a first-in-class CD228-targeted costimulatory antibody anticalin® bispecific delivering potent and conditional 4–1BB costimulation to tumor-specific T cells
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address